Medical Diagnostic
Abbott Secures FDA Approval For Volt PFA System, Advancing Atrial Fibrillation Treatment In The United States
Abbott's Volt™ PFA System, the latest generation of cardiac ablation technology, is designed for people battling heart rhythm d...
December 29, 2025 | News
BrioHealth Solutions Reaches 100th Patient Enrollment In INNOVATE LVAD Trial
BrioHealth Solutions announces it has reached a major milestone with the 100th enrollment in the INNOVATE Trial of the BrioVAD® System, a Lef...
December 26, 2025 | News
HKSH Medical Group And Shenzhen Cancer Hospital Formalise Proton Therapy Collaboration Under Healthy China 2030 Framework
In alignment with the national framework for the advancement of proton therapy, facilitated by the National Cancer Center, HKSH Medical Group ("HKSH")...
December 25, 2025 | News
Solventum Completes Acquisition Of Acera Surgical To Strengthen MedSurg And Wound Care Portfolio
Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space in acute care settings in the U.S. Accelerates Solventum's bu...
December 24, 2025 | News
Japan Approves Guardant360 CDx As First Blood Based Companion Diagnostic For ESR1 Mutations In Breast Cancer
Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-posit...
December 23, 2025 | News
Japan Approves Incyte’s Zynyz As First Line Treatment For Advanced Anal Canal Cancer
Incyte Biosciences Japan G.K. announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination w...
December 23, 2025 | News
Alphamab Oncology’s JSKN003 Gains FDA Breakthrough Therapy Designation For Platinum Resistant Ovarian Cancer
Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, independently developed by the...
December 23, 2025 | News
Qihan Biotech Initiates Phase I IIa Dosing Of Allogeneic CAR T Therapy For Refractory Lupus
Qihan Biotech, a clinical-stage biotechnology company developing off-the-shelf cell therapies for autoimmune diseases and cancer, including allogeneic CAR-...
December 22, 2025 | News
Soin Neuroscience And BIOTRONIK Neuro Advance Personalised Spinal Cord Stimulation Research
Soin Neuroscience and BIOTRONIK Neuro announced a research collaboration to advance personalized spinal cord stimulation (SCS) tuning using Soin Neuroscien...
December 22, 2025 | News
Colour CT Breakthrough Reaches Europe As Charles University Adopts Advanced MARS Scanner
MARS Bioimaging, a New Zealand–headquartered medical device company specialising in spectral molecular imaging CT scanners that deliver colour 3D X-r...
December 19, 2025 | News
UK Hospitals Adopt AI Tool MEMORI To Strengthen Early Detection Of Hospital Acquired Infections
Sanome, the health tech company behind MEMORI, an AI-powered clinical decision support tool that helps clinicians detect hospital-acquired infections (HAIs...
December 18, 2025 | News
ALZpath Licenses pTau217 Antibody To Siemens Healthineers To Expand Blood Based Alzheimer’s Diagnostics
ALZpath, Inc., a leading developer of innovative diagnostic tools for Alzheimer’s disease and related dementias, announced a licensing ag...
December 17, 2025 | News
Peijia Medical Secures China Regulatory Approval For TaurusTrio Transcatheter Aortic Valve System
Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, a...
December 16, 2025 | News
AusperBio Reports 30% Functional Cure Rate With AHB 137 In Chronic Hepatitis B
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company developing oli...
December 16, 2025 | Report
Most Read
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
